2159 — Mediwelcome Healthcare Management & Technology Cashflow Statement
0.000.00%
- HK$91.00m
- HK$67.80m
- CNY321.56m
- 28
- 47
- 54
- 37
Annual cashflow statement for Mediwelcome Healthcare Management & Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 22.3 | 5.59 | -91 | -96.4 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.24 | 6.29 | 12.7 | 22.5 | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -10.1 | -31.1 | 39.2 | -22.2 | — |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 31.1 | 0.262 | -18.5 | -75.6 | — |
Capital Expenditures | -13.8 | -25 | -4.3 | -1.6 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 2.83 | 8.22 | -4.06 | 18.1 | — |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -11 | -16.8 | -8.36 | 16.5 | — |
Financing Cash Flow Items | -0.896 | -1.26 | -1.25 | -1.3 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4.79 | 92.8 | 0.054 | 0.906 | — |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 15.3 | 76.3 | -26.8 | -58.2 | — |